Alegeus has long been recognized as one of the original innovators in the consumer-directed healthcare (CDH) market. The company’s strong position as an innovator was recently reaffirmed by the United States Patent and Trademark Office (USPTO), granting Alegeus new patents in the essential areas of multi-purse adjudication and debit-card enablement of multi-purse benefit plans.

“Alegeus’ thought leadership and proud legacy of innovation have once again been affirmed with the grant of these important patents,” said Leif O’Leary, Alegeus CEO. “We remain committed to leveraging our unparalleled depth of expertise to advance and protect our Partner-Powered indirect market strategy.”

With these new patents added to its existing portfolio, Alegeus continues to shape the future of CDH solutions and remains a driving force in transforming the landscape of healthcare finance.

About Alegeus

With 30 years of growth and innovation, Alegeus is the market leader in SaaS-based benefit funding and payment solutions. Our highly flexible, white-label platform powers account-based benefit programs such as HSAs, FSAs, HRAs, COBRA, wellness incentives, lifestyle benefits and beyond. We deliver exceptional user experiences and differentiate capabilities that help our partners strengthen their product offerings, operate more efficiently, and unlock their full growth potential. Our partnerships with the industry’s leading health plans, third-party administrators, financial services and benefit solution providers give Alegeus unparalleled reach in the market. Alegeus is headquartered in Boston, Mass., with operations centers in Orlando and Bangalore, and a large remote workforce.